Discovery of novel TACE inhibitors using graph convolutional network, molecular docking, molecular dynamics simulation, and Biological evaluation
Entdeckung neuer TACE-Inhibitoren mit graph convolutional network, molecular docking, molecular dynamics simulation und biologischer Evaluation
PLOS ONE · 27.12.2024 · 19 (12) · e0315245
DOI: 10.1371/journal.pone.0315245 ↗Auf einen Blick
Mit einem Deep-Learning-Ansatz wurde unter FDA-zugelassenen Arzneimitteln ein potenzieller TACE-Inhibitor identifiziert. Vorinostat zeigte in der biologischen Prüfung eine vergleichbare TACE-Hemmung.
Fragestellung
Können mit einem integrierten Deep-Learning- und Screening-Ansatz FDA-zugelassene Arzneimittel mit TACE-hemmender Wirkung identifiziert werden?
Methode
Integratives Deep-Learning-Modell mit anschließender traditioneller Wirkstoffsuche; Nutzung von DUD-E-Daten, RDKit und GraphConvMol in DeepChem; Docking und molekulare Dynamik mit BMS-561392 als Referenz.
Ergebnisse
Vorinostat wurde als potenzieller TACE-Inhibitor identifiziert. Docking und molekulare Dynamik zeigten starke Bindungen an zentrale TACE-Reste; in RAW 264.7-Zellen bestätigte die biologische Prüfung eine vergleichbare Hemmwirkung.
Schlussfolgerung der Autor:innen
Die Autoren heben hervor, dass Deep-Learning-Modelle Virtual Screening in der Wirkstoffsuche verbessern können; Vorinostat sei ein neu identifizierter TACE-Inhibitor mit weiterem Forschungsbedarf.
Kernaussagen
- Vorinostat wurde als potenzieller TACE-Inhibitor identifiziert
- Docking und molekulare Dynamik stützten das Ergebnis
- Biologische Prüfung in RAW 264.7-Zellen zeigte vergleichbare Hemmung
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 27.12.2024. Verfasst von Muhammad Yasir und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Kangwon National University School of Medicine, Chuncheon, Republic of Korea. Hauptthemen laut MEDLINE: ADAM17 Protein, Molecular Docking Simulation, Molecular Dynamics Simulation. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NHGRI NIH HHS, Institute of Medical Sciences, Kangwon National University.
Abstract (Originalsprache)
The increasing utilization of deep learning models in drug repositioning has proven to be highly efficient and effective. In this study, we employed an integrated deep-learning model followed by traditional drug screening approach to screen a library of FDA-approved drugs, aiming to identify novel inhibitors targeting the TNF-α converting enzyme (TACE). TACE, also known as ADAM17, plays a crucial role in the inflammatory response by converting pro-TNF-α to its active soluble form and cleaving other inflammatory mediators, making it a promising target for therapeutic intervention in diseases such as rheumatoid arthritis. Reference datasets containing active and decoy compounds specific to TACE were obtained from the DUD-E database. Using RDKit, a cheminformatics toolkit, we extracted molecular features from these compounds. We applied the GraphConvMol model within the DeepChem framework, which utilizes graph convolutional networks, to build a predictive model based on the DUD-E datasets. Our trained model was subsequently used to predict the TACE inhibitory potential of FDA-approved drugs. From these predictions, Vorinostat was identified as a potential TACE inhibitor. Moreover, molecular docking and molecular dynamics simulation were conducted to validate these findings, using BMS-561392 as a reference TACE inhibitor. Vorinostat, originally an FDA-approved drug for cancer treatment, exhibited strong binding interactions with key TACE residues, suggesting its repurposing potential. Biological evaluation with RAW 264.7 cell confirmed the computational results, demonstrating that Vorinostat exhibited comparable inhibitory activity against TACE. In conclusion, our study highlights the capability of deep learning models to enhance virtual screening efforts in drug discovery, efficiently identifying potential candidates for specific targets such as TACE. Vorinostat, as a newly identified TACE inhibitor, holds promise for further exploration and investigation in the treatment of inflammatory diseases like rheumatoid arthritis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Kangwon National University School of Medicine, Chuncheon, Republic of Korea.
- Department of Medical Environmental Biology and Tropical Medicine, Kangwon National University School of Medicine, Chuncheon, Republic of Korea.
- Department of Physiology, Kangwon National University School of Medicine, Chuncheon, Republic of Korea.
- The Steve and Cindy Rasmussen Institute for Genomic Medicine at Nationwide Children's Hospital, Columbus, Ohio, United States of America.
ORCID-Profile: Wanjoo Chun
Förderung
- NIGMS NIH HHS
- NHGRI NIH HHS
- Institute of Medical Sciences, Kangwon National University
- Korea Basic Science Institute
- National Institute of Health
Zitieren
APA
Yasir, M., Park, J., Han, E. T., Han, J. H., Park, W. S., Hassan, M., Kloczkowski, A., & Chun, W. (2024). Discovery of novel TACE inhibitors using graph convolutional network, molecular docking, molecular dynamics simulation, and Biological evaluation. PLOS ONE, 19(12), e0315245. https://doi.org/10.1371/journal.pone.0315245
Vancouver
Yasir M, Park J, Han ET, Han JH, Park WS, Hassan M, et al. Discovery of novel TACE inhibitors using graph convolutional network, molecular docking, molecular dynamics simulation, and Biological evaluation. PLOS ONE. 2024;19(12):e0315245. doi:10.1371/journal.pone.0315245
BibTeX
@article{Yasir2024,
author = {Yasir, Muhammad and Park, Jinyoung and Han, Eun-Taek and Han, Jin-Hee and Park, Won Sun and Hassan, Mubashir and Kloczkowski, Andrzej and Chun, Wanjoo},
title = {Discovery of novel TACE inhibitors using graph convolutional network, molecular docking, molecular dynamics simulation, and Biological evaluation},
journal = {PLOS ONE},
year = {2024},
volume = {19},
number = {12},
pages = {e0315245},
doi = {10.1371/journal.pone.0315245}
}
EUVIMED